About the Foundation

The Foundation for Cancer Research Support (RakFond) is a non-profit organization whose main tasks include: financing research and development activities, development of new methods and tools for the prevention, diagnosis and treatment of cancer, promoting the development and improvement of research and scientific activities of research institutions, scientific centers, oncological hospitals, and individual specialists in the field of oncology. The Foundation was founded in 2017 and operates on the territory of the Russian Federation.

NEWS

VIEW ALL

18 Apr

STUDY SUPPORTED BY RAKFOND WILL BE PRESENTED AT ASCO ANNUAL MEETING

Final results of the randomized phase II trial supported by Rakfond will be presented by its author Dr. Alexey Rumyantsev at the Annual Meeting of the American Society of Clinical Oncology (ASCO)... more

15 Apr

FIRST RESEARCH SUPPORTED BY RAKFOND HAS BEEN COMPLETED

The clinical trial to evaluate the efficacy of the novel drug combination for chemotherapy-induced nausea & vomiting (CINV) prophylaxis has been successfully completed... more

9 Apr

WINNER THE ONCOMMUNOLOGY COMPETITION WILL STUDY EFFICIENCY MECHANISMS OF A NEW CELL IMMUNOTHERAPY

The winner of the research project competition funded jointly by RakFond and SciStoreLab, LLC is Dr. Emil Bulatov,... more

5 Apr

RESULTS OF THE RESEARCH PROJECTS COMPETITION RFP 2018-02

The research project competition funded jointly by the NPO “Foundation for Cancer Research Support” (RakFond) and SciStoreLab, LLC has been completed... more

1 Mar

ANNUAL REPORT ON THE RESULTS OF RAKFOND'S ACTIVITIES IN 2018

The report contains detailed descriptions of the supported research, events, financials, and collaborations... We look forward to the continuation of our joint efforts in 2019... more

30 Dec

MARIYA STEPANOVA: END OF THE YEAR SUMMARY

Grantee of the first joint RUSSCO-RakFond competition among young oncologists Mariya Stepanova shares her results and impressions of the 2018 research year as well as her future plans... more

Information and Reports

View All

15 Feb

American Society of Clinical Oncology (ASCO) Issues the 14th Annual Report on Progress Against Cancer

ASCO’s Clinical Cancer Advances 2019 highlights the most significant clinical research advances of the past year and identifies priority areas where research efforts should be focused to accelerate progress against cancer... more

28 Dec

2018 RESEARCH YEAR: ONCOLOGY NEWS

The area of oncology in 2018 was full of events and news, new studies results, some of them were practice-changing. Here we publish selected interesting news of this year... more

19 Dec

MOTIVATION AND ROLE OF CLINICAL TRIALS FOR AN ONCOLOGIST’S SUCCESSFUL CLINICAL PRACTICE

By Timur Mitin, MD, PhD, Associate Professor of Radiation Medicine at Oregon Health and Science University, Medical Director of the Tuality/OHSU Cancer Center (Portland, USA). more

19 Oct

Cancer statistics: incidence and mortality

This September the International Agency for Research on Cancer (IARC) issued the 2018 update of the GLOBOCAN – the online tool which contains data on incidence and mortality for 36 cancers in 185 countries... more

18 Sep

Annual Cancer Progress Report Issued by the American Association for Cancer Research

The American Association for Cancer Research (AACR) has released its annual Cancer Progress Report, which describes how research improves survival and quality of life for people around the world... more

Interviews with experts

RakFond's experts talk in their short interviews about their choice to become an oncologist, which cancer research they could name as their favorite, and why cancer research support is important.

Interview with Jacek Gronwald

Interview with Jacek Gronwald, PhD, Professor, Department of Genetics and Pathology, Pomeranian Medical University (Szczecin, Poland), Member of RakFond's Scientific Advisory Board. Learn about hereditary cancers, studies of lifestyle factors in oncology... more

Interview with Alexey Danilov

Interview with Alexey Danilov, Associate Professor of Medicine, Division of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Science University (Portland, USA), Member of RakFond's Scientific Advisory Board...Learn about research translation from bench to bedside, the discovery and research of the novel therapies in hematologic malignancies... more

Interview with Alexey Tryakin

Interview with Alexey Tryakin, M.D., D.Sci., Chief Scientist, Department of Clinical Pharmacology and Chemotherapy of N.N. Blokhin National Medical Research Center of Oncology (Moscow, Russia)... Learn about the inception of the targeted therapy in oncology, what advantages of participating in clinical trials bring to doctors and patients... more

Interview with Irina Demidova

Interview with Irina Demidova, M.D., Ph.D., Head of Molecular Diagnostic Laboratory, Moscow Oncological Hospital #62 (Russia)... Learn about the role of molecular diagnostics in oncology, which research is most often translated into the clinical practice... more

Interview with Timur Mitin

Interview with Timur Mitin, M.D., Ph.D., Associate Professor of Radiation Medicine at Oregon Health and Science University... Learn more about radiation oncology, the significance of the organ-conserving treatment... more

Interview with Nikolay Zhukov

Interview with Nikolay Zhukov, M.D., D.Sci., Professor, Head of Department of Interdisciplinary Oncology, D. Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology (Moscow, Russia)... Learn how to define the boundary between an effective and an ineffective treatment methods... more

About the Foundation

NEWS

Information and Reports

Interviews with experts

Our Supporters